| |
| |
|
| Insider
Information: |
Manhard Kimberly |
| Relationship: |
EVP, Drug Development |
| City: |
Lafayette |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
28,330 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$66,292 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
28,330 |
|
|
| Total
Value |
$66,292 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ardea Biosciences Inc |
RDEA |
SVP, Regulatory & Dev ... |
2012-06-19 |
0 |
2009-05-19 |
0 |
Premium* |
|
|
Heron Therapeutics Inc |
HRTX |
EVP, Drug Development |
2023-04-13 |
28,330 |
2015-06-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| HRTX |
Heron Therapeutics Inc |
EVP, Drug Development |
• – – |
2023-04-13 |
4 |
D |
$2.88 |
$4,081 |
D/D |
(1,417) |
28,330 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
EVP, Drug Development |
• – – |
2023-04-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,814 |
29,747 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
EVP, Drug Development |
• • – |
2023-01-13 |
4 |
D |
$3.17 |
$6,378 |
D/D |
(2,012) |
23,933 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
EVP, Drug Development |
• • – |
2023-01-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,814 |
25,945 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
EVP, Drug Development |
• • – |
2022-10-31 |
4 |
A |
$3.27 |
$5,416 |
D/D |
1,655 |
20,131 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
EVP, Drug Development |
• • – |
2022-10-13 |
4 |
D |
$3.76 |
$7,565 |
D/D |
(2,012) |
18,476 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
EVP, Drug Development |
• • – |
2022-10-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,814 |
20,488 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
EVP, Drug Development |
• • – |
2022-07-13 |
4 |
D |
$3.01 |
$6,056 |
D/D |
(2,012) |
14,674 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
EVP, Drug Development |
• • – |
2022-07-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,814 |
16,686 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
EVP, Drug Development |
• • – |
2022-05-03 |
4 |
AS |
$4.76 |
$7,154 |
D/D |
(1,504) |
10,872 |
0 |
% |
|
| HRTX |
Heron Therapeutics Inc |
EVP, Drug Development |
• • – |
2022-04-29 |
4 |
A |
$3.84 |
$5,778 |
D/D |
1,504 |
12,376 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
EVP, Drug Development |
• • – |
2022-01-13 |
4 |
D |
$8.30 |
$16,700 |
D/D |
(2,012) |
7,070 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
EVP, Drug Development |
• • – |
2022-01-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,814 |
9,082 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
EVP, Drug Development |
• • – |
2021-10-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,250 |
3,701 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
EVP, Drug Development |
• • – |
2021-10-13 |
4 |
D |
$10.55 |
$4,568 |
D/D |
(433) |
3,268 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
EVP, Drug Development |
• • – |
2021-07-13 |
4 |
D |
$13.48 |
$5,837 |
D/D |
(433) |
2,451 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
EVP, Drug Development |
• • – |
2021-07-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,250 |
2,884 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
EVP, Drug Development |
• • – |
2021-05-03 |
4 |
AS |
$17.66 |
$27,009 |
D/D |
(1,529) |
1,634 |
0 |
% |
|
| HRTX |
Heron Therapeutics Inc |
EVP, Drug Development |
• • – |
2021-04-30 |
4 |
A |
$13.90 |
$21,249 |
D/D |
1,529 |
3,163 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
EVP, Drug Development |
• • – |
2021-04-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,250 |
2,067 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
EVP, Drug Development |
• • – |
2021-04-13 |
4 |
D |
$16.66 |
$7,214 |
D/D |
(433) |
1,634 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
EVP, Drug Development |
• • – |
2021-01-13 |
4 |
D |
$18.16 |
$7,863 |
D/D |
(433) |
817 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
EVP, Drug Development |
• • – |
2021-01-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,250 |
1,250 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
EVP, Drug Development |
• • – |
2020-12-22 |
4 |
AS |
$20.00 |
$200,000 |
D/D |
(10,000) |
0 |
0 |
% |
|
| HRTX |
Heron Therapeutics Inc |
EVP, Drug Development |
• • – |
2020-12-22 |
4 |
OE |
$13.00 |
$130,000 |
D/D |
10,000 |
10,000 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
